Skip to main content

ACOs must act now to get ahead of MSSP changes



Redesigned MSSP program

The Medicare Shared Savings Program, one of Medicare’s largest alternative payment models, allows providers and suppliers the opportunity to form an Accountable Care Organization. It was redesigned in 2018, establishing “Pathways to Success” as a way to restructure participation and encourage ACOs to transition to two-sided risk models. 

As part of this rule, a BASIC track was established for ACOs to begin participation under an upside-only risk model and to incrementally phase into a two-sided risk model through a glide path. The glide path is composed of Levels A through E, in which there is progressively greater financial risk and potential opportunity for savings. 

It is critically important for ACOs to understand how their level of participation in MSSP will change in the coming years.

COVID-19 impact on MSSP advancement

The COVID-19 public health emergency has disrupted efforts to improve population health and care coordination, and has resulted in a lack of predictability within ACOs in relation to service utilization, beneficiary assignment and cost sharing.

Provisions in the FY 2022 Medicare Hospital IPPS and LTCH Rates Proposed Rule would allow ACOs to elect to remain in the same level of the glide path for performance year 2022 if the effects of the PHE continue to be felt.

ACOs that elect to maintain their level in the glide path during performance year 2021 and/or PY 2022, due to the PHE, would automatically transition to the level of risk they would have been in for PY 2023. 

Key considerations for ACOs

The good news for ACOs is that CMS has recognized that the PHE will likely impact patient care patterns into 2022. As ACOs are feeling more risk-averse, continued flexibility in their participation is needed to keep them in the MSSP program. 

However, ACOs that maintain a low risk level during the PHE would need to prepare to face a much higher level of risk when PY 2023 begins. For example, an ACO at Level A for PY 2020 whose level of participation was maintained for PY 2021 and 2022 would enter PY 2023 at Level D, which is a higher level of risk. Level D participation would increase the shared savings rate from 40% to 50% and shared losses rate from 0% to 30%. 

ACOs must prepare for the impact these changes may have on their organizations, whether they decide to maintain their current participation level or advance along the glide path for the next year. 

Connect with DataGen to assess the financial implications of MSSP changes for your organization and to make more informed decisions for future success.

Popular posts from this blog

The Future of Healthcare: Top Trends Providers Need to Address Now

As we emerge from a global pandemic, accountable care organizations must address key new trends now to maintain progress toward value-based care and mitigate financial risk.  Analytics are key to helping ACOs gain a better understanding of trends so they can identify opportunities to drive quality improvement. These trends include: gaps in access to clinical care;  shifts in patient volume; increased demand for virtual care; and  social determinants of health challenges.  To better understand rising trends and actions providers should take, we will reach out to hospital and health system leaders to discuss how recent trends influenced their decision to adopt value-based contracts. Then, during our July 28 webinar, we will release a comprehensive market report on these trends and implications for the future. Preventing gaps in access to clinical care Advanced payment models incentivize ACOs to deliver high-quality care and close gaps in care for patients, thereby earning shared savings

Three more years of CJR: What participating hospitals need to know

On April 29, CMS issued a final rule to extend the Comprehensive Care for Joint Replacement model by an additional three performance years. A number of modifications effective in the extension period aim to improve the model and reflect Medicare policy changes over the last several years. CMS anticipates that CJR will save the Medicare program an additional $217 million over the extension period. The following summarizes the most notable model changes: Three new performance years have been added: PY 6 will include episodes that end between Oct. 1, 2021 and Dec. 31, 2022; PY 7 will include episodes that end between Jan. 1, 2023 and Dec. 31, 2023; and PY 8 will include episodes that end between Jan. 1, 2024 and Dec. 31, 2024. Episode definitions under the model have been expanded to include total hip arthroplasty and total knee arthroplasty procedures performed in the hospital outpatient setting. The episode categories under the extension are site-neutral and are defined as: MS-DRG 470: